Shows
Deep Dive by Diversified MediaThe Bankruptcy Strategy at the Center of the Talc Lawsuits | Full Breakdown#DeepDive #JohnsonAndJohnson #TalcLawsuits #Bankruptcy #MassTortsThis episode of Deep Dive by Diversified Media examines one of the most controversial legal strategies in modern corporate litigation: Johnson & Johnson's efforts to resolve massive talc-related liabilities through bankruptcy proceedings.For years, Johnson & Johnson has faced thousands of lawsuits alleging that certain talc-based products contributed to serious illnesses, including ovarian cancer and mesothelioma. As litigation expanded, the company pursued a series of legal maneuvers designed to address these claims through the bankruptcy system rather than traditional mass tort litigation.This episode explores how the strategy developed, why...
2026-06-0811 minDeep Dive by Diversified MediaThe Billion-Dollar Baby Powder Lawsuits | Full Breakdown#DeepDive #BabyPowderLawsuits #JohnsonAndJohnson #MassTorts #ProductLiabilityThis episode of Deep Dive by Diversified Media examines the massive wave of litigation involving baby powder products and one of the most significant product liability battles in modern American history.Over the years, thousands of plaintiffs have alleged that long-term use of talc-based baby powder products contributed to the development of serious illnesses, including ovarian cancer and mesothelioma. Manufacturers have disputed many of these claims, leading to years of litigation, scientific debate, appeals, jury verdicts, settlements, and corporate restructuring efforts.This episode explores how the litigation began...
2026-06-0821 min
Dividend Investing with Fexingo: Income Stocks, Yield, and Long-Term Cash Flow PortfoliosHow Dividend Investors Can Navigate a Hot Jobs ReportLucas and Luna break down how the surprisingly strong May jobs report, released June 5, 2026, reshapes the outlook for dividend investors. With the Fed Funds rate stuck at 3.63 and Chair Warsh signaling no cuts soon, they drill into two specific plays: Realty Income (O) up 2.2% in five days, and Altria (MO) surging 5.2%. What do these moves tell us about sector rotation in a 'higher for longer' world? The hosts also discuss why dividend growth stocks like Procter & Gamble and Johnson & Johnson are catching bids, while high-growth tech gets hammered. A practical episode for anyone building a cash-flow portfolio in mid-2026.
2026-06-0506 minDividend Investing with Fexingo: Income Stocks, Yield, and Long-Term Cash Flow PortfoliosHow Dividend Growth Stacks Up Against High Yield in Mid-2026In this episode, Lucas and Luna compare dividend growth investing with high-yield strategies, using real mid-2026 data for Coca-Cola, Realty Income, and Johnson & Johnson. They analyze how a 2.8% drop in KO and a 2.5% drop in O affect income portfolios, and discuss whether chasing yield is worth the risk. The hosts also examine the current 10-year Treasury yield at 4.49% and the Fed funds rate at 3.63%, explaining how these rates shape dividend stock performance. Perfect for income investors looking to balance current income with long-term growth.
#DividendGrowth #HighYield #CocaCola #RealtyIncome #JohnsonAndJohnson #DividendInvesting #IncomeStocks #TreasuryYields #FedFundsRate #PortfolioStrategy #KO #O #JNJ...
2026-06-0507 min
Social Media Marketing with Fexingo: Instagram, TikTok, LinkedIn, and Platform StrategyHow Brands Use Social Media for Product Recalls and Safety NoticesEpisode 31 of Social Media Marketing with Fexingo explores a high-stakes use of social platforms: product recalls and safety notices. Lucas and Luna break down how brands like Toyota and Johnson & Johnson have used Instagram, TikTok, and LinkedIn to quickly communicate with consumers when things go wrong. They discuss the 2019 Fisher-Price Rock 'n Play recall that reached millions via social, why video demonstrations outperform text-only posts, and how a recall strategy can actually build trust if done transparently. Specific examples include Toyota's 2023 airbag recall campaign that used Instagram Reels to walk owners through VIN checks, and how a small pet...
2026-06-0408 minDividend Investing with Fexingo: Income Stocks, Yield, and Long-Term Cash Flow PortfoliosHow Dividend ETFs VYM SCHD and DVY Diverge in Mid-2026Episode 30 of Dividend Investing with Fexingo breaks down the recent performance divergence between three popular dividend ETFs: VYM, SCHD, and DVY. As of early June 2026, VYM is up 1.4% over five days while SCHD and DVY have slipped. Lucas and Luna explore what's driving the split—sector composition, yield vs. growth tilt, and fund methodology. They zoom in on SCHD's underperformance tied to its overweight in consumer staples like Procter & Gamble and Johnson & Johnson, both down roughly 4% and 3% respectively in the same period. They also discuss how a flattening yield curve and steady Fed policy favor VYM's broader value exposure. Th...
2026-06-0409 min
Family Business Stories with Fexingo: Succession, Legacy, and Multi-Generational CompaniesHow the Janssen Family Built a Global Pharmaceutical GiantIn this episode, Lucas and Luna explore how the Janssen family turned a small Belgian lab into one of the world's most influential pharmaceutical companies. They focus on the pivotal role of Dr. Paul Janssen, who personally discovered over 80 drugs, including fentanyl and haloperidol. The conversation examines the 1961 sale to Johnson & Johnson, the unique 'entrepreneurial autonomy' deal that kept the Belgian R&D engine intact for decades, and the tensions that arose as Johnson & Johnson's corporate culture gradually encroached. Specific numbers include the $1.5 billion annual R&D budget at the peak and the 5,000-plus compounds the lab synthesised. The...
2026-06-0212 minDividend Investing with Fexingo: Income Stocks, Yield, and Long-Term Cash Flow PortfoliosHow Dividend Investors Can Use DRIP During Market PullbacksIn episode 26 of Dividend Investing with Fexingo, Lucas and Luna explore how dividend reinvestment plans (DRIP) can amplify returns when the market dips. With the S&P 500 at 7,600 and Realty Income down 4.2% over five days, the hosts explain why dollar-cost averaging through DRIP compounds shares faster during pullbacks. They use Coca-Cola (down 2.3%) and Johnson & Johnson (down 2.9%) as examples, showing how reinvesting dividends at lower prices boosts long-term compounding. The episode also touches on the difference between broker DRIP and issuer DRIP, tax considerations, and how to set up automatic reinvestment. A brief donation segment reminds listeners that ad-free episodes...
2026-06-0206 min
Crisis Management with Fexingo: Recessions, Layoffs, and Business Survival StoriesHow Johnson and Johnson Handled the Tylenol CrisisIn this episode of Crisis Management with Fexingo, Lucas and Luna dive into the 1982 Tylenol cyanide poisonings and how Johnson & Johnson's response became the gold standard for crisis management. They explore the specific decisions CEO James Burke made within the first 48 hours, the cost of recalling 31 million bottles, and how the company rebuilt trust with tamper-evident packaging. Lucas connects the Tylenol playbook to modern crises, referencing the current low VIX of 15.80 as a sign of market complacency—and asks whether today's leaders would make the same tough calls. Luna challenges the narrative with data: J&J's market share fell fr...
2026-06-0107 min
Enterprise Tech with Fexingo: Fortune 500 Software, Procurement, and Large-Account SalesHow Fortune 500s Are Using Procurement Finance Integration for Cash FlowEpisode 23 of Enterprise Tech with Fexingo dives into the growing trend of procurement-finance integration among Fortune 500 companies. Lucas and Luna explore how firms like Procter & Gamble and Johnson & Johnson are connecting procurement systems directly with treasury and working capital platforms to unlock cash, reduce payment cycles, and negotiate better terms. They unpack a specific case: how one consumer goods giant used real-time procurement data to cut days payable outstanding by 12 days, freeing up nearly $300 million in cash. The episode also touches on the role of APIs, the shift from static payment terms to dynamic discounting, and why procurement is...
2026-05-3112 min
The Productivity Podcast with Fexingo: Output, Efficiency, and Long-Term Economic GrowthWhy Your Health Is the Biggest Productivity LeverThis episode examines how physical health directly shapes economic productivity at the individual and national level. Lucas and Luna dig into a 2023 Rand Corporation study that quantified the productivity loss from chronic conditions like back pain, depression, and diabetes in the US workforce. They discuss the concept of presenteeism—showing up sick or in pain—and how it costs the economy hundreds of billions a year more than absenteeism. The hosts also explore why employers underinvest in preventive health benefits, comparing the cost of a gym membership subsidy to the return on reduced sick days and better cognitive performance. Thro...
2026-05-3110 minDividend Investing with Fexingo: Income Stocks, Yield, and Long-Term Cash Flow PortfoliosDividend Stock Correlations in May 2026In this episode of Dividend Investing with Fexingo, Lucas and Luna explore the often-overlooked correlation between dividend stocks and the broader market, using recent May 2026 data. While the S&P 500 is up 1.4% over five days, many high-dividend names like Coca-Cola, Johnson & Johnson, and Altria have fallen 3-6%. Lucas explains that dividend stocks can act as a low-beta anchor in rallies but also lag when growth is the narrative. They discuss how investors can use correlation data to balance a portfolio, avoid the trap of buying high-yield stocks that simply track the index, and identify which dividend payers are true...
2026-05-3108 min
The Financial Freedom Podcast with Fexingo: Quitting Your Job, Living Off Investments, IndependenceThe Dividend Portfolio That Funds Your Early RetirementIn this episode, Lucas and Luna explore a less-talked-about early retirement strategy: building a dividend-focused portfolio that generates enough passive income to cover living expenses without selling shares. They use a detailed hypothetical example: a 40-year-old couple with a $1.2 million portfolio targeting a 3.5% dividend yield — $42,000 per year — supplemented by a part-time consulting gig. Lucas explains why dividend stocks can reduce sequence-of-returns risk compared to total-return withdrawal strategies, and Luna pushes back on the tax inefficiency and concentration risk. They break down three dividend aristocrats (Coca-Cola, Johnson & Johnson, Procter & Gamble) as examples, discuss the importance of diversification across sectors, and expl...
2026-05-2913 minDividend Investing with Fexingo: Income Stocks, Yield, and Long-Term Cash Flow PortfoliosHow Dividend Stocks Cushion a Flattening Yield CurveIn this episode, Lucas and Luna explore a structural shift in fixed-income markets that dividend investors need to understand: the flattening yield curve. With the 10-year Treasury yield at 4.48% and the 2-year at 4.00%, the spread has narrowed to 46 basis points. Lucas explains why this environment historically favors dividend-paying equities over bonds, especially when rates are stable. He points to the S&P 500's 1.6% weekly gain alongside standout dividend stocks like Procter & Gamble, which rose 1.8% in five days. Luna asks whether the market is pricing in a rate cut by year-end, and they discuss how dividend growers with strong free...
2026-05-2908 minEnterprise Tech with Fexingo: Fortune 500 Software, Procurement, and Large-Account SalesHow the Fortune 500 Is Using Supplier Portals to Cut CostsEpisode 15 of Enterprise Tech with Fexingo. Lucas and Luna explore how Fortune 500 companies are deploying supplier portals to streamline procurement, reduce maverick spending, and enforce compliance. The episode centers on a specific case: Johnson & Johnson's rollout of a unified supplier portal across its 260 operating companies, which cut procurement cycle times by 40 percent and saved an estimated $300 million annually. Lucas breaks down the key features—digital catalogs, automated onboarding, and real-time performance dashboards—and why legacy ERP systems alone can't achieve these results. Luna questions whether supplier pushback is a hidden cost, and they discuss how companies like Pfizer and Proc...
2026-05-2706 minEnterprise Tech with Fexingo: Fortune 500 Software, Procurement, and Large-Account SalesHow The Fortune 500 Is Automating Procurement with AI AgentsIn this episode of Enterprise Tech with Fexingo, Lucas and Luna dive into the quiet revolution happening inside Fortune 500 procurement departments: AI agents that negotiate contracts, flag supplier risks, and automate purchase orders. They focus on the specific case of Johnson & Johnson, which deployed an AI-powered procurement agent from Coupa across its 250 operating companies. Lucas explains how the agent reduced purchase-order cycle time from four days to four hours, while Luna questions whether this is incremental automation or a genuine shift in how enterprises manage spend. They also discuss the tension between procurement teams who love the efficiency and...
2026-05-2609 minDividend Investing with Fexingo: Income Stocks, Yield, and Long-Term Cash Flow PortfoliosDividend Safe Withdrawal Rates in May 2026Lucas and Luna explore how dividend investors should think about withdrawal rates in the current yield environment. With the S&P 500 at 7,473 and the 10-year Treasury at 4.57%, traditional safe withdrawal rate rules of thumb need updating. They drill into the specific case of a retiree relying on high-dividend stocks versus a combination of dividend growers and bonds, using real data from May 26, 2026. Lucas explains why a 4% withdrawal rule may be too aggressive when starting yields are elevated, and why a 3.5% rate with a tilt toward dividend growers like Johnson & Johnson (up 2.4% in the last five days) can improve sustainability...
2026-05-2610 minDividend Investing with Fexingo: Income Stocks, Yield, and Long-Term Cash Flow PortfoliosWhy Dividend Growers Beat High-Yield Stocks in 2026Lucas and Luna dig into a critical distinction for income investors: the difference between a stock that pays a high dividend today and one that grows its dividend reliably over time. Using real May 2026 data, they compare the five-day performance of high-yield stalwarts like Verizon (+3.4%) and Altria (+0.2%) against dividend growers like Johnson & Johnson (+2.4%) and Procter & Gamble (+1.4%). They explore the math behind dividend growth compounding, the risk of yield traps in a falling-rate environment, and why Johnson & Johnson's 2.4% yield might be more valuable than Verizon's 5.4% yield over a decade. The episode closes with a practical framework for building a dividend...
2026-05-2507 minDividend Investing with Fexingo: Income Stocks, Yield, and Long-Term Cash Flow PortfoliosHow Dividends Are Beating Treasuries in May 2026With the 10-year Treasury yield hovering near 4.57% and the 2-year at 4.08%, income investors face a surprising choice: bonds finally offer competition, yet dividend stocks like Verizon, Coca-Cola, and Johnson & Johnson are still outperforming over the past week. Lucas and Luna dig into why — focusing on the tax advantage of qualified dividends, the flat yield curve that favors equities, and the behavioral reality that dividend growers provide total return that Treasuries cannot match. They reference specific live data: VZ up 3.4% in five days, JNJ up 2.4%, while the 10Y-2Y spread narrowed to 43 basis points. If income is the goal, this ep...
2026-05-2405 minEnterprise Tech with Fexingo: Fortune 500 Software, Procurement, and Large-Account SalesWhy SAP Concur Is Pushing Hotel Procurement Into the 21st CenturyLucas and Luna break down how SAP Concur is quietly transforming the way Fortune 500 companies procure hotel rooms for business travel. They focus on the company's 2025 push to integrate direct hotel inventory into its booking platform, bypassing traditional global distribution systems like Sabre and Amadeus. The hosts explore the economics behind the shift — Concur charges hotels a 3 percent commission versus the legacy GDS fee of 10 to 15 percent — and what it means for travel managers at companies like Johnson & Johnson and Procter & Gamble. They also discuss the tension between procurement cost savings and traveler choice, and whether this model could spre...
2026-05-2309 minDividend Investing with Fexingo: Income Stocks, Yield, and Long-Term Cash Flow PortfoliosDividend Aristocrats Look Cheap in May 2026This episode explores why dividend aristocrats — companies with 25+ years of consecutive dividend increases — are trading at attractive valuations relative to history in May 2026. Lucas and Luna examine the recent pullback in blue-chip dividend payers, including Procter & Gamble and Johnson & Johnson, despite broad market strength. They discuss how the inverted yield curve has suppressed demand for income stocks, and whether current price-to-earnings ratios for aristocrats signal a buying opportunity for long-term income investors. The hosts also consider the risk of dividend freezes in a shifting rate environment and why sector diversification matters when building a dividend growth portfolio.
#Divi...
2026-05-2208 minDividend Investing with Fexingo: Income Stocks, Yield, and Long-Term Cash Flow PortfoliosWhy Dividends Beat Bonds in May 2026With the 10-year Treasury yield falling from 4.67% to 4.57% and the yield curve flattening, Lucas and Luna explain why high-quality dividend stocks like Verizon and Johnson & Johnson are offering a meaningful yield premium over bonds. They break down the dividend growth story versus bond coupon stability, using real market data from May 22, 2026. If you're wondering whether to allocate to equities or fixed income right now, this episode gives you a framework.
#DividendInvesting #Bonds #Yield #IncomeStocks #Verizon #JohnsonAndJohnson #TreasuryYield #YieldCurve #PortfolioStrategy #May2026 #FexingoDividend #Finance #Business #FexingoBusiness #BusinessPodcast #Investing #DividendGrowth #BondAlternative
Keep every episode free: buymeacoffee.com/fexingo
2026-05-2207 minDividend Investing with Fexingo: Income Stocks, Yield, and Long-Term Cash Flow PortfoliosDefensive Dividend Stocks Outperforming in May 2026Lucas and Luna explore why defensive dividend stocks like Verizon, Johnson & Johnson, and Procter & Gamble have been outperforming the S&P 500 in May 2026. With the 10-year Treasury yield climbing to 4.67% and the yield curve steepening, investors are rotating into high-quality income names. Verizon is up 4% in five days, JNJ up 2.1%, and PG up 1.4%, compared to the S&P's 0.5% gain. The hosts discuss whether this is a signal of caution or just a yield grab, and what it means for long-term dividend growth portfolios. They also touch on the impact of rising bond yields on dividend stocks and the importance...
2026-05-2107 minDividend Investing with Fexingo: Income Stocks, Yield, and Long-Term Cash Flow PortfoliosWhen Dividend Growth Lags the S&P What to WatchIt's May 2026, and dividend stocks are in a curious spot. With the 10-year Treasury yield above 4.6% and the S&P 500 roughly flat over the past week, income investors are asking whether dividend growth can keep pace with inflation and market returns. Lucas and Luna dig into a concrete case: Johnson & Johnson, which has raised its dividend for 62 consecutive years but whose 5-year dividend growth rate has slipped below 5%. They compare J&J's trajectory with Procter & Gamble, which is growing its payout faster, and weigh the trade-offs between current yield and dividend growth. They also look at the broader dividend...
2026-05-2108 min
LexHive Podcast (Formerly- Legal Growth Lab by DemandLane)Inside the Johnson & Johnson Talc Scandal: $4.4B, Bankruptcy Tricks & Lawyer Wars with Thomas GrajekInside one of the most complex legal battles of our time: the talcum powder lawsuits against Johnson & Johnson, billion-dollar verdicts, and the chaos behind mass tort litigation.In this episode, we break down the 15-year war over talc and cancer claims, including the landmark $4.4 billion verdict led by Mark Lanier, and how courtroom storytelling, science, and strategy shaped one of the biggest legal outcomes in history.But that’s just the beginning.We go deeper into:How talcum powder lawsuits actually work (Mass Torts vs Class Actions)?The science debate: Does talc really cause cancer?Why billions are at...
2026-04-131h 34
theexp.meJNJ - Dividend King 63 ปีที่มี Lawsuit 67,000 คดี ยังน่าลงทุนหรือเปล่า?JNJ - Dividend King 63 ปีที่มี Lawsuit 67,000 คดี ยังน่าลงทุนหรือเปล่า?Johnson & Johnson เป็น Dividend King ที่จ่ายปันผลเพิ่มขึ้นติดต่อกัน 63 ปี แต่ขณะนี้มีคดี Talc litigation กว่า 67,115 คดีคงค้างอยู่ โดย potential exposure อาจสูงถึง $10–15Bสิ่งที่ดี: Darzalex ยาหลักทำรายได้ $14.4B ปี 2025 โต +22% และ Carvykti (CAR-T) กำลัง ramp +67% ในไตรมาสล่าสุด Cardiovascular MedTech โต +16% FCF $19.7–20.4B ต่อปี 2026 guidance revenue $100.5Bแต่หุ้นขึ้นมา +44.5% ใน 1 ปีแล้ว RSI overbought ที่ 78.67 consensus PT $253.87 = upside เหลือแค่ 7%Entry ที่ดีกว่าอาจเป็น $220–225 หากมี pullback#theexpme #JNJ #JohnsonAndJohnson #หุ้นสหรัฐ #DividendKing
2026-04-0807 min
The Book Brief ProjectNo More Tears: The Dark Secrets of Johnson & Johnson by Gardiner Harris | Summary and Review🎙️ Disclaimer: I’ve been told my natural speaking voice is better suited for a construction site than a sleep podcast. To prevent any accidental eardrum damage, I use high-quality AI narration for these episodes. The scripts are researched by me (with some AI help), but the voice is 100% digital and 100% more relaxing than mine.How much do you really trust the brands in your medicine cabinet? 🧴💨For over a century, Johnson & Johnson was the "Gold Standard" of corporate ethics. We trusted them with our babies, our pain relief, and our families...
2026-04-0215 min
Temporally ScriptedCow Uses Tools, Elephant Kills 22 People & The Welsh Health Ambassador ControversySend us Fan Mail⚡ EPISODE 41! Solar storms mess with Jack's crystals, Johnson & Johnson faces 67,500 cancer lawsuits, and a one-tusked elephant in India has killed 22 people. Plus: AI caught memorizing entire copyrighted books word-for-word.⏰ TIMESTAMPS:00:00 Intro - Solar Storms & Jingling Crystals03:00 Solar Flares Could Send Us to Stone Age10:00 Johnson & Johnson Talc: 67,500 Cancer Cases15:00 Welsh Health Ambassador Sparks Controversy18:00 UK Plans to Ban Social Media for Under-16s32:00 AI Caught Stealing Copyrighted Books42:00 Cow Named Veronica Learns to Use Tools47:00 One-Tusked Elephant: India's Serial Killer52:00 🪙 TOP 5 WEIRD CURRENC...
2026-01-251h 01
Catch the DriftThe Most Anticipated Earnings Release for the Week of January 19, 2026The most anticipated earnings releases for the week of January 19, 2026, are Netflix #NFLX, Intel #INTC, Intuitive Surgical #ISRG, Procter & Gamble #PG, United Airlines #UAL, Johnson & Johnson #JNJ, 3M Company #MMM, Interactive Brokers #IBKR, Fifth Third Bancorp #FITB, and Halliburton #HAL.https://www.earningswhispers.com/calendar #mostanticipated #earningsseason #earnings #earningscalendar #earningswhispers #netflix #intel #johnsonandjohnson #pandg #procterandgamble #united #unitedairlines #3m #intuitivesurgical #geaerospace #interactivebrokers #fifththirdbank #earningswhispers
2026-01-1903 min
Progress, Potential, and Possibilities Podcast / ShowJoel Krikston - Managing Director Venture Investments, Merck Global Health Innovation Fund / Co-Founder, MSD Idea Studios - Investments To Improve Patients' LivesSend us Fan MailJoel Krikston is a seasoned executive with extensive experience in venture investments and strategic innovation within the healthcare sector.Joel currently serves as Managing Director Venture Investments Merck Global Health Innovation Fund ( https://www.merckghifund.com/?profile=joel-krikston ) and Co-Founder of MSD Idea Studios ( https://www.msd.de/ideastudio/ ), a global innovation hub organization that is committing $38 million to scale high-impact health technologies that directly align with Merck’s access and R&D priorities. They are strategically located in the innovation hubs of Singapore and Berlin. With a career spa...
2025-10-2357 min
Sobering Stories PodcastDoes TYLENOL Really CAUSE AUTISM???💊 If you can’t tough it out, then you can support the sponsor,but otherwise do not support the sponsor ❤️🚨 Tylenol's Coal-Tar Secret 🤫#TylenolAutism #JandJScandals #BigPharmaExposed #SoberingStoriesEver pop that red bottle thinking it's grandma's gentle fix? Turns out, it's born from 19th-century war sludge—Big Pharma's idea of a plot twist. In this Sobering Stories dig, we unearth acetaminophen's buried lab flubs (1878 to Elixir boom), the 2025 prenatal autism buzz (20-30% higher odds?), and J&J's slide from bandage saints to poison peddlers: Cyanide dumps, talc ghosts, and a rogue's gallery of faults that scream deflection. Is it real risk... or cabal smoke fo...
2025-10-171h 13Progress, Potential, and Possibilities Podcast / ShowDr. Mark Lloyd Davies - Global Head, Strategic Partnerships and Resource Group, Johnson & Johnson - Strategic Public-Private Partnerships To Transform LivesSend us Fan MailDr. Mark Lloyd Davies, Ph.D. is the Global Head for the Strategic Partnerships and Resource Group at Johnson & Johnson ( https://www.jnj.com/ ) where he leads a global team that forges novel strategic public-private partnerships to secure collaborations that accelerate groundbreaking R&D, advances strategies that widen access to care for patients and health systems worldwide, and ultimately unlocks possibilities that transform lives.Dr. Davies has built a distinguished career at the intersection of science, policy, and global health strategy.Before taking on his current global role, Dr...
2025-09-3039 min
Ian & Rashad Present Black Out Unfiltered UncutTrump, Tylenol & Autism: Breaking Down the ControversyIn this thought-provoking clip from "Black Out with Ian & Rashad," your favorite hosts dive deep into the recent controversy sparked by Donald Trump’s administration warning about the use of Tylenol during pregnancy and its alleged link to autism. Rashad and Ian unpack what was actually said, the internet’s explosive reaction, and the complexities surrounding medical advice when it comes to pregnancy.Rashad starts by quoting Trump’s claim and discusses the subsequent FDA response, including potential warnings for pregnant women and whether there were already existing cautions or risks previously noted. Ian chimes...
2025-09-2708 min
Toxic Exposures, Cancer Lawsuits & Justice: Mesothelioma, Defective Drugs, Radiation Injuries, Environmental Contamination & Legal Settlements Explained.Talcum Powder Ovarian Cancer Lawsuits | Johnson & Johnson Baby Powder Cancer Risks, Asbestos Exposure, Legal Settlements, Compensation Claims & Justice for Women Worldwide.This episode uncovers the truth about talcum powder ovarian cancer lawsuits, focusing on Johnson & Johnson’s baby powder and its hidden asbestos contamination. For decades, women trusted talcum powder as a safe product, only to discover its direct link to ovarian cancer. Billions of dollars in settlements have already been awarded, yet thousands of cases are still pending in courts across the U.S. and UK. Learn how medical studies exposed corporate negligence, why regulators failed to protect consumers, and what victims can do today to claim justice. We break down step-by-step how lawsuits work, what evidence is required, an...
2025-09-1401 min
Toxic Exposures, Cancer Lawsuits & Justice: Mesothelioma, Defective Drugs, Radiation Injuries, Environmental Contamination & Legal Settlements Explained.Talcum Powder Ovarian Cancer Lawsuit | Johnson & Johnson Baby Powder Claims, Women’s Health Justice & Billion-Dollar Settlements.In this episode, we uncover the truth behind the talcum powder ovarian cancer lawsuits that shook the corporate world. For decades, Johnson & Johnson’s baby powder was marketed as safe for daily use. Later, medical studies revealed a possible link between talc products and ovarian cancer in women. Thousands of victims have filed lawsuits, and courts have already awarded multi-billion-dollar settlements. We’ll explain the science, legal claims, and how you may still qualify to join ongoing litigation.#TalcumPowderLawsuit #OvarianCancerClaims #JohnsonAndJohnson #WomensHealthJustice #HighCompensation #LegalAwareness #DefectiveProduct
2025-09-1401 min
Toxic Exposures, Cancer Lawsuits & Justice: Mesothelioma, Defective Drugs, Radiation Injuries, Environmental Contamination & Legal Settlements Explained.Talcum Powder Ovarian Cancer Lawsuits: Johnson & Johnson, Asbestos Contamination, Women’s Health Crisis, Corporate Negligence & Multi-Billion Dollar Settlements.For decades, women trusted talcum powder for hygiene. But hidden inside was asbestos contamination, linked to ovarian cancer and mesothelioma. Thousands of women filed lawsuits exposing corporate negligence and failure to warn consumers. Courts have already ordered multi-billion dollar settlements against Johnson & Johnson.This episode uncovers the truth behind the talcum powder lawsuits, women’s health battles, and the pursuit of justice.#TalcumPowderLawsuits #OvarianCancerAwareness #JohnsonAndJohnson #AsbestosContamination #CorporateNegligence #MultiBillionDollarSettlements #WomenHealthJustice #HighRPMPodcast
2025-09-1201 min
Toxic Exposures, Cancer Lawsuits & Justice: Mesothelioma, Defective Drugs, Radiation Injuries, Environmental Contamination & Legal Settlements Explained.Risperdal Gynecomastia Lawsuits: Dangerous Antipsychotic Drug, Male Breast Growth, Johnson & Johnson Negligence & Billion-Dollar Settlements.Risperdal, an antipsychotic drug, was prescribed to children and young men. But many developed gynecomastia – abnormal male breast growth, causing trauma and permanent physical changes. Lawsuits against Johnson & Johnson have led to multi-billion dollar verdicts.This episode uncovers the truth about Risperdal lawsuits, corporate negligence, and justice for victims.#RisperdalLawsuits #GynecomastiaAwareness #DrugSideEffects #JohnsonAndJohnson #CorporateNegligence #LegalCompensation #HighRPMPodcast #MultiBillionDollarSettlements
2025-09-1200 min
Stuttering in SilenceThe Capsule Killer: The Tylenol Murders of 1982In this chilling episode of Stuttering in Silence, Matt and Gavin take us back to Chicago in 1982 — when ordinary bottles of Tylenol turned into weapons of mass fear. Seven people died in just days, and America’s most trusted pain reliever suddenly became the face of terror.Together, the hosts unpack how Johnson & Johnson went from “America’s family company” to the center of a national panic, the shocking recall that rewrote corporate crisis management forever, and the haunting theories about who really laced those capsules with cyanide. From the bearded man caught on tape, to James Lewis’s ex...
2025-09-041h 02
Red White & BiEpisode 12 - The Margaret Thatcher of Our TimeHannah & Ash discuss the deaths of Ozzy Osborne and Hulk Hogan, the Missouri Abortion Pill lawsuit, whether the so-called treason case against Obama is a distraction from the non-release of the Epstein files, and Elon Musk's America Party.#Musk #Elon #Epstein #Gabbard #Trump #America #Party #Treason #Missouri #Abortion #JohnsonAndJohnson #Tylenol #murders #rich #Thatcher #AmericanCapitalistParty #DrowningMona #WolfOfWallStreet #DiCaprio #MarkPellegrino #LOST #Television #Movies #Politics #Bush #Reagan #Republican #Democrat
2025-07-2733 min
Wisdom at a GlanceThe Curse of Baby Powder – Johnson & Johnson’s Darkest Secrets | Asbestos, Risperdal, Fentanyl🧴 The Curse of Baby Powder is a stunning exposé by former NYT journalist Gardiner Harris.Based on court documents, whistleblowers, and years of reporting, it reveals the shocking history of Johnson & Johnson.In this video, we explore:• Asbestos in baby powder and ovarian cancer links• Risperdal’s side effects and aggressive marketing• Fentanyl abuse and the Duragesic scandal• FDA’s regulatory failure and media silence• Tens of thousands of lawsuits and what it all means for us💡 This is not just abou...
2025-07-1104 min
Beka - Resumen de Mercados"Chupinazo" en los ARANCELES de Trump | Actualidad de Mercados | 07 07 25Semana intensa en los mercados: Trump reaviva la guerra comercial con nuevos aranceles, Europa muestra signos de debilidad económica y la Reserva Federal mide sus movimientos. ¿Qué esperar esta semana? ¿Y cómo posicionarse?
#mercadosfinancieros #economía #aranceles #Trump #FED #inflación #tiposdeinterés #exportaciones #déficit #EEUU #Europa #China #macro #JohnsonandJohnson #inversión #ETF #rentaVariable #rentaFija #datosmacro #IPC #defensa #Ucrania #volatilidad #SanFermín #RealMadrid #euro #dólar #BCE #sectorautomoción #industriaalemana
2025-07-0706 min
Make It Count : the SneakyG podcast🎉 Episode 300! Giants Legends, Jersey Battles & SneakyG’s Big Campaign Moment | Make It CountIt’s the BIG 3-0-0! In this landmark episode of Make It Count: The SneakyG Podcast, we celebrate 300 epic episodes of Giants passion with all-out energy, heart, and legendary guests! 💙🧢You’ll hear:🔥 Iconic interviews with Tiki Barber, Leonard Marshall and Eli Mack🏈 Favorite Giants jerseys of all time — and the reasons behind them🤣 A surprise Johnson & Johnson sponsorship campaign?💯 Fan shoutouts, wild debates, and pure Big Blue loveThis episode is a celebration of YOU — the fans who’ve been there through every lik...
2025-06-163h 00
The Dr. Josh Axe ShowJohnson & Johnson – The Biggest Medical Conspiracy in U.S. HistoryIs one of the most “trusted” names in healthcare responsible for millions of deaths? This explosive interview may change everything you thought you knew about the medical system.
In this eye-opening episode of The Dr. Josh Axe Show, Dr. Axe sits down with Pulitzer-nominated investigative journalist and former New York Times correspondent Gardiner Harris to expose the dark underbelly of Big Pharma—specifically the disturbing history of Johnson & Johnson.
Gardiner, who has reported from the White House and covered the pharmaceutical industry for decades, joins the show to discuss revelations from his groundbreaking new book No Mor...
2025-05-2259 min
Market MondaysTrump’s Prescription Drug Order, Amazon’s AMD Power Play & Future of Healthcare StocksIn this insightful Market Mondays clip, Rashad Bilal, Ian Dunlap, and Troy Millings break down two of the week’s biggest financial headlines that could shake up the markets: President Trump’s executive order to lower prescription drug prices and Amazon’s strategic acquisition of AMD shares. First, the hosts dive deep into the possible long-term impacts of Trump’s new executive order aiming to slash prescription drug costs across the board. They discuss the potential winners—everyday consumers in need of lower medication costs—and the possible losers, notably major pharmaceutical companies that may see prof...
2025-05-1707 min
SAM&PAM's Book RadarBaby Powder, Opioids & Hidden Scandals: A Deep Dive into J&J's 'No More Tears' InvestigationNo More Tears: The Dark Secrets of Johnson & Johnson by Gardiner Harris (Published 2025) available on Amazon: https://amzn.to/42wpydv[Using our affiliate links helps support the content we create]Dive into Gardiner Harris's gripping investigation, No More Tears: The Dark Secrets of Johnson & Johnson, a hazard mystery that unravels the hidden truths behind one of America's most iconic companies. From consumer products like baby powder to prescription drugs such as Procrit and Risperdal, and medical devices like hip implants and vaginal mesh, Harris meticulously uncovers a pattern of conduct that belies Johnson & Johnson's pristine...
2025-04-1615 min
PantheonAIMarket Momentum: Bank of America Surges, Crypto Climbs, Fund Managers Turn BearishWelcome to the PAI Morning Briefing for April 15, 2025. I’m your host from PantheonAI, bringing you the latest insights into today’s financial markets.Market Overview:S&P 500: Up 0.5% to 5,439.27Dow Jones: Increased by 0.46% to 40,716.37Nasdaq: Rose 0.58% to 16,940.44Bitcoin: Surged 2.11% to $86,350.82Ethereum: Gained 2.0% to $1,654.74Key Highlights:Bank of America reported a 10% profit increase in Q1 2025, with earnings reaching $7.4 billion, driven by strong consumer spending and trading revenue .Inv...
2025-04-1510 min
🤖🧬 Where Technology Meets Science#2 Pharma Brief: AI’s Impact on Clinical Trials, Must-See Open Source Tools, and Upcoming Pharma EventsPharma Brief is back with the latest edition, packed with valuable insights and upcoming events you don’t want to miss. This month, we’re exploring AI’s impact on clinical development (trials could be 30% faster!), along with innovative tools that streamline processes. We’ve also highlighted open-source packages to optimize your workflows.You can follow Pharma Brief on LinkedIn: https://www.linkedin.com/newsletters/pharma-brief-7300489155535380480/ And now it’s available in audio on all your favorite podcasting platforms.Links from the episode:NVIDIA’s “State of AI in Healthcare and Life Sciences” Report: https://blogs.nvidia.com/blog...
2025-04-0205 min
The Eric Deters ShowTrump Takes Over NCAA Wrestling – Fans Go Nuts | Eric Deters ShowTrump Takes Over NCAA Wrestling – Fans Go Nuts | Eric Deters Show National Welcome to a power-packed lineup brought to you by Eric Deters Media! “All The News You Need!” ”Rapid News!” * Eric Deters Show: Join Eric as he dives deep into today's top stories, providing insightful analysis and candid discussions on the issues that matter. * Eric Deters World News in a Minute! * Eric Deters Sports Without Boundaries: Get ready for an adrenaline-packed adventure as Eric explores the world of sports without limits. From thrilling victories to unexpected upsets, we've got your sports fix covered with the ultimate entertainment from the Bulldo...
2025-03-2410 minBeka - Resumen de MercadosMake Europe Great Again: ¿Europa toma la delantera en mercados? | Actualidad de Mercados | 17 03 25Los mercados han vivido una semana de altibajos: caídas abruptas, rebotes inesperados y grandes movimientos en renta variable y fija. ¿Qué está pasando con la inflación, la confianza del consumidor y la política monetaria? Descubre las claves del mercado y qué esperar en los próximos días.
#Bolsa #Inversión #MercadosFinancieros #Trading #Economía #Acciones #ETF #RentaVariable #FED #Inflación #WallStreet #NASDAQ #DowJones #SP500 #Oro #RentaFija #Estrategia #AnálisisFinanciero #Geopolítica #Trump #Europa #China #Alemania #Inditex #JohnsonAndJohnson #FondosDeInversión #Recesión #ReservaFederal #TiposDeInterés #Inversiones #Consumo #DeudaCorporativa #estrategiafinanciera
2025-03-1707 min
Talent DraupStrategic Workforce Planning in the Healthcare Sector with Cody MartinIn the first-ever episode of Talent Draup, Vijay Swaminathan, CEO of Draup, sits down with Cody Martin, the Director of Total Workforce Management at Johnson & Johnson, to explore the evolving landscape of talent intelligence and strategic workforce planning. Cody shares insights on identifying hidden competitors, leveraging AI-driven skills architectures, and effectively aligning talent strategies with business goals.Cody emphasizes that a company’s competitors for talent are not always in the same industry. For multifaceted organizations like Johnson & Johnson, competitors might include tech giants or supply chain leaders. Recognizing these hidden competitors through talent flow analysis is cr...
2025-03-1126 min
Justice ForTylenol Murders In 1982, 7-seemingly random people died after taking Tylenol. As police worked quickly to find a connection, the manufacturer, Johnson and Johnson, jumped into action as well. Setting the standard for how a company should respond when their product is responsible for the deaths of innocent people. Join us as we share the story of the Tylenol Murders and hopefully find Justice For the 7 innocent victims. Disclaimer The views and opinions expressed in this podcast are those of the hosts and do not necessarily reflect the views of any affiliated organizations. All suspects are considered innocent until...
2025-03-1136 min
Success After ServiceEpisode 6: Shannon KellyFrom Navy Pilot to Healthcare Leader | Shannon Kelly’s Transition to Civilian Success
Shannon Kelly had to be confident as a Navy pilot—lives depended on it. But stepping into the civilian workforce? That was a whole new challenge. She faced uncertainty, struggled to adjust her direct military communication style, and wondered if she’d ever find a career with purpose.
Today, she’s thriving as an Orthopaedic Account Director at Johnson & Johnson, negotiating contracts and pricing for J&J MedTech customers across the Pacific Northwest. Her role gives her the same sense of mission she had in the Navy—hel...
2025-02-0324 min
Political Views TVNews and views for May 1, 2024. PVTV, political views TV#PatriotMissiles #Ukraine, #Russian #Uranium, #Norway #UkraineAid, #Weapons #Deliveries, #Poland vs #Ukraine #Conscriptions, #Belgorod #Voronezh #Ryazav #Kursk, #OilRefinery, #Odesa, #Kharkiv, #Donetsk, #CeaseFire #Israel #Hamas, #Columbia #StudentProtest, #Trump vs #Netanyahu, #China vs #Philippines, #Haiti, #HouseDemocrats #TrumpsJohnson, #Florida #AbortionLaw, #Arizona #Abortion #Repeal, #Louisiana #Gerrymandering, #Trump #GagOrder #Incarceration, #Congress vs #BigOil, #Marijuana #ScheduleIII, #JohnsonAndJohnson vs#ClassAction, #TheFed
2024-05-0147 min
New Mission Career TransitionA Career in Recruiting, Marketing, & Leadership | Pat D'Amico | USA🤔 To work in corporate or a start-up…THAT is the question! 🤔
Our guest, Pat D'Amico, served as a military police officer in the U.S. Army. After his military career, he transitioned into pharmaceutical sales, recruiting, marketing, training program development, and product development before starting his own company, About-Face Development LLC. (About-Face! IYKYK)
In this episode, Pat tells us about…
✅ Working for a Large Corporation
✅ The Startup Vibe
✅ Recruiting vs. Marketing
✅ New Bis Owner Mistakes
✅ Hiring from the Manager Perspective
✅...
2024-02-061h 07
The Saturday Report w/ Colt Sebastian Taylor9/16/23 The Saturday Report w/ Colt Sebastian TaylorThe Saturday Report w/ Colt Sebastian Taylor for September 16th, 2023.
Looking to buy a Chevy or get one serviced? Check out Bob Fisher Chevrolet and Troutman's Chevrolet Buick GMC.
Check out Smart News, a great app for your phone where you can get multiple news sources on practically any topic. Am I on there? No. At least not yet.
Need a good Social Media Posting platform, try out Social Bee. It is what I use across the Colt Sebastian Taylor Social Media Network.
...
2023-09-1642 minPolitical Views TVNews and views for July 14, 2023. PVTV, political views TV#ASEAN regional forum, #Poland vs #Russia, #Putin vs #WagnerGroup #Prigozhin, #RussianSpy #Deportation to #US, #Belgorod, #Kursk, #SAGAFTRA #Strike, #StudentLoanDebt #Forgiveness, #WhiteSupremacy in #Congress, #GOP #CongressionalPayRaise, #NewYork #Redistricting, #Water #Protections #EPA, #JohnsonAndJohnson vs #Science, #Heat #HistoricRecord, #India #TheMoon
2023-07-1428 min
Börsen Podcast - Mathias Christen#049 - Johnson & Johnson Aktienanalyse - Lohnt sich jetzt ein Einstieg?Johnson & Johnson ist ein globales Gesundheitsunternehmen, das sich auf die Entwicklung und Vermarktung von Medizinprodukten, Pharmazeutika und Verbraucherprodukten konzentriert. In diesem Video werfen wir einen Blick auf die einzelnen Segmente von Johnson & Johnson, um herauszufinden wie gesund das Unternehmen dasteht und wie es sich in Zukunft entwickeln könnte.
Wie immer beurteile ich die Aktie auch anhand des Fair Values und prüfe mit Hilfe der Chartanalyse, ob sich ein Einstig bei der Aktie lohnen könnte.
📞Vereinbare jetzt Dein kostenfreies Beratungsgespräch: https://mathiaschristen.com/
Inhaltsverzeichnis:
0:00 Intro
1:20 Kursverlauf über 5 Jahre im Vergleich mit AbbVie, Pfizer und dem S&P500
2:51 Überblick...
2023-05-2642 min
KnowelloJohnson & Johnson offers $9bn to settle Talc cancer claims
The first Johnson & Johnson talc cancer claims surfaced in the early 2000s when several studies suggested a possible link between talc-based products and ovarian cancer.
#Business #Science #Global #Cancer #johnsonandjohnson #Lawsuit #Healthcare #Brands #talcumpowder #knowelloapp
Sources: LiveMint, Economic Times, BBC
2023-04-1001 min
El Playbook del PoderInvertir En Programas De Salud Y Bienestar Para Los Colaboradores
Sebastián meléndez nos habla acerca de lo importante de invertir en programas de salud y bienestar para los colaboradores
¿Está buscando aumentar la productividad, reducir el absentismo y mejorar la salud y el bienestar de los colaboradores? Invertir en programas de salud y bienestar para los colaboradores es la respuesta. Aprenda por qué y cómo puede beneficiar a su empresa. Desde iniciativas sencillas hasta programas integrales, descubra por qué es algo que deben saber todos los líderes de negocios. ¡No se pierda esta valiosa información!
Visite:
https://www...
2023-03-3104 min
El Playbook del PoderInvertir En Programas De Salud Y Bienestar Para Los ColaboradoresSebastián meléndez nos habla acerca de lo importante de invertir en programas de salud y bienestar para los colaboradores
¿Está buscando aumentar la productividad, reducir el absentismo y mejorar la salud y el bienestar de los colaboradores? Invertir en programas de salud y bienestar para los colaboradores es la respuesta. Aprenda por qué y cómo puede beneficiar a su empresa. Desde iniciativas sencillas hasta programas integrales, descubra por qué es algo que deben saber todos los líderes de negocios. ¡No se pierda esta valiosa información!
Visite:
https://www.ifmglobal.g...
2023-02-1804 min
Behind the Line Podcast: Pacific Northwest Politics and Constitutional CommentaryRegeneron antibody treatmentYouTube won't allow videos to be posted that have the keywords antibody or antibody treatment or regeneron. So what is regeneron's colonal antibody treatment listening for more information. Also are you aware that the Johnson & Johnson vaccine is not MRNA? #covid #covid19 #antibody #antibodytreatment #covidtreatment #j&j #johnsonandjohnson #regeneron #antibodies
2021-11-0907 min
TRSIWe tied our debt to a goat and forced it off into the deserthttps://www.reuters.com/investigates/special-report/johnsonandjohnson-cancer/
2021-10-1544 min
Beyond The NewsBeyond The News with Jim Grant E 52
Comedian/ Opinionated news repeater monkey, Jim Grant with his weekly satirical look at the news. https://www.facebook.com/BeyondTheNews. and https://www.facebook.com/JimGrantComedy
Telegram
@beyondthenewsjim
Parler
https://parler.com/profile/Beyondthenews
https://www.msn.com/en-gb/news/other/dr-david-bauer-pfizer-vaccine-produces-fewer-key-antibodies/vi-AAKHPO1?fbclid=IwAR1n5sJ3XlDVhftw4ceT5rY-MpYbGT9goQ9ilYWZUMdBgcJJZ2WcfkW_YSU
https://www.foxbusiness.com/technology/facebook-whistleblower-sophie-zhang-severance?cmpid=fb_fnc&fbclid=IwAR12kYCo1uYPgUcZLimjxfQvCjBGI5xSmJHTpQAAN2E-17eS-yDe6_vrWTY
https://www.foxbusiness.com/technology/facebook-whistleblower-big-tech-breakups-section-230-fight-against-bots?cmpid=fb_fnc&fbclid...
2021-08-0659 min
The DUM Show#186: Dentists are evil? Vaccine worries? National Pride.12JUL21: PAGING DR. HOOKENCLAW The Dentist is one of the worst appointments that one has to keep. I review my own struggles with the Dentist Office, some gruesome photos, and a positive, yet humorous spin on the event. WE’VE GOT THE WHOLE WORLD IN CHINA’S HANDS The US women’s national soccer team is denying team members turned their backs on a 98-year-old World War II veteran as he played the national anthem before an exhibition game, claiming that some players were simply looking at the flag at the other end of the stadium. “Get your facts straight before y...
2021-07-1358 min
Nieuw FinancieelDividend AristocratsDividend AristocratsBinnen het dividendbeleggen heb je weer verschillende vormen van beleggen. Zo kun je beleggen in hoog dividend, maar ook in groeidividend aandelen en profiteren van dividenduitkeringen. Daarmee heb je een vast inkomen per maand, per kwartaal of per jaar. Binnen dividendbeleggen is het fijn om wat extra zekerheid te hebben, want je weet nooit wat er met een bedrijf of dividend gaat gebeuren. Zekerheid heb je nooit volledig, maar met Dividend Aristocrats toch wel wat meer dan normaal. Dividend Aristocrats zijn een veilige , betrouwbare investering. Behalve dat deze bedrijven een goede staat van dienst hebben...
2021-06-0304 min
Stuff You Should Know About IPEP 32: Should Big Pharma Give Up COVID-19 Vaccine Patent Rights?Should "Big Pharma" give up their patent rights to the new COVID-19 vaccines for the sake of mankind? Billionaire tech giant turned philanthropist; Bill Gates says “NO.” But, President Joe Biden says… maybe? Today’s episode features special guest Ben Hoopes, Patent Counsel at HP to discuss this topic. #intellectualproperty #IP #ipstrategy #patent #patentrights #iprights #pharma #covid #covid-19, #vaccine #pfizer #moderna #astrazeneca #johnsonandjohnson #billgates #joebiden #worldtradeorganization #WTO
2021-05-1926 min
Coding With StrangersWhy Is Texas Rushing To Open ? Greg Abbott Doesn't Think So, Because Johnson and Johnson ?Hey Identifier,
#Texas #johnsonandjohnson #gregabbott
Help Send a Kid in Need to College
https://www.gofundme.com/f/endurance-24-award
Shopping on Amazon? Support Small Youtubers via my link, cost you nothing its FREE
https://amzn.to/3rowFjU
Leave us a Voice Mail
https://anchor.fm/the-identity-booth/message
Donate
https://streamlabs.com/projecteto/tip
The Goal: Try to Identify with you as you try to Identify with me.
Find Heero
here: https://linktr.ee/the_identity_Booth
Find Eric
h...
2021-04-2316 min
CBiz TV Media- The MixVaccine ControversyWhat are your thoughts on the #CoronaVirus #Vaccine? We talk about that and our own thoughts. Questions? Comments? Email cbiztv@yahoo.com #Pfizer #Moderna #JohnsonAndJohnson #BloodClots #Controversy #Rights #Choice #Opinion #Safety #Masks #herdImmunity #CDC #PSA For Coronavirus Updates: https://www.cdc.gov/coronavirus/2019-ncov/index.html
2021-04-2015 min
RRP Porch TalkShade & Shenanigans RRP Porch Talk Episode 32You are listening to the RRP Porch Talk Podcast Shade & Shenanigans Edition.During this episode we discuss:⭐️Daunte Wright being “accidentally” killed by police⭐️The Army Lieutenant that was assaulted with pepper spray⭐️Derrick Jaxn and Camron go at it on social media⭐️The Johnson and Johnson vaccine being halted because of it causing blood clots and moreCo- hosts: Whitney, Senaca, GP, and Black@mywhitneyb @jabari_mfn_darkoe34.@blackco81@that_is_gpPlease feel free t...
2021-04-1855 min
WhyGo to weekend#sidejob #work #proactive #anticipate #anticipation #hustle #vaccine #johnsonandjohnson #film #create #production #commercial #acting #television #movie #short #shortfilm --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/appSupport this podcast: https://anchor.fm/anthony-crescenzo/support
2021-04-1508 min
John Riley ProjectCharles Barkley on Politicians and DivisionCharles Barkley said what many of us think, but rarely hear in the mainstream media. The politicians are dividing us and getting us fighting amongst ourselves so they can stay in power. We break down Barkley’s video clip from the NCAA Final Four and then go through a list of examples how these two political parties are playing a game on the people. Plus, I share my vaccination story.
#CharlesBarkley #vaccine #JohnsonandJohnson
JRP0221
Referenced Links:
Charles Barkley speaks the Truth on Racial Matters in America
https://www.youtube.com/watch...
2021-04-081h 11
Highdeas PotcastJefeCast 3/7/2021On this jammed pack edition of the #JefeCast I cover a women with #2vaginas gets #pregnant #sexworker charged with #murder after #7rounds working him to death #cicadasreturn #johnsonandjohnson #donaldtrump makes the news again I review #soylentgreen and the #wandavision series #localnews #gorillagluegirl health scare #naomicampbell #50yearsyoung #joeexotic #ti #buttimplantsburst #liluzi and sooo much more
2021-03-121h 23Highdeas PotcastJefeCast 3/3/2021On this edition of the #JefeCast I talk about #shaq debuting on #AEW #Lakers woes #AllstarWeekend #NBA #Stimulus Update #MsMarvel #Kentucky #StateOfEmergency #JohnsonandJohnson #vaccines and more.
2021-03-1239 min
Clark County Today LIVECCTL • Thursday, March 4, 2021TODAY: Clark County COVID hospitalizations drop again ; Vancouver Public Schools tabs Camas Superintendent for same role ; Vancouver Police Drug Task Force under the spotlight ; Lawmakers steering Interstate Bridge Replacement Project have different priorities than the community ; Paul Valencia previews Friday Night football games.
WATCH: Join us at 6 p.m. on ClarkCountyToday.com, Facebook or YouTube for today's local news updates! Watch and find links to these stories here: http://bit.ly/CCT_LIVE_21_03_03
#ClarkCountyToday #ClarkCountyTodayLive #LocalNews #ClarkCountyWa #LiveBroadcast #COVID19 #Coronavirus #Teachers #Educators #Vaccination #JohnsonandJohnson #JNJ #JohnsonAndJohnsonVaccine #AlzheimersAssociation #Alzheimers #DispairtyIssues #CampHope #BattleGroundWa #ClarkCollege #SpringSports #CollegeSports
2021-03-0507 min
Health CARES, A Nurse's PerspectiveA Little Covid This and A Little Covid That - Part 1 of 2Have all of your Johnson and Johnson vaccine questions answered in this episode. #Covid #Covidvaccine #JohnsonandJohnson
2021-03-0530 min
Health CARES, A Nurse's PerspectiveA Little Covid This and A Little Covid That - Part 1 of 2Have all of your Johnson and Johnson vaccine questions answered in this episode. #Covid #Covidvaccine #JohnsonandJohnson
2021-03-0530 min
Clark County Today LIVECCTL • Wednesday, March 3, 2021TODAY: K–12 educators now eligible for vaccine ; Johnson & Johnson vaccine approved ; Alzheimer’s Association looks at disparity issues ; Camp Hope reopens in Battle Ground ; Clark College passes on spring sports.
WATCH: Join us at 6 p.m. on ClarkCountyToday.com, Facebook or YouTube for today's local news updates! Watch and find links to these stories here: http://bit.ly/CCT_LIVE_21_03_03
#ClarkCountyToday #ClarkCountyTodayLive #LocalNews #ClarkCountyWa #LiveBroadcast #COVID19 #Coronavirus #Teachers #Educators #Vaccination #JohnsonandJohnson #JNJ #JohnsonAndJohnsonVaccine #AlzheimersAssociation #Alzheimers #DispairtyIssues #CampHope #BattleGroundWa #ClarkCollege #SpringSports #CollegeSports
2021-03-0406 min
The Nick Margerrison podcast0026 INTERVIEW | Greg Carlwood of The Higher Side ChatsOur guest's internet home is here: https://www.thehighersidechats.com/ Johnson and Johnson link: https://www.reuters.com/investigates/special-report/johnsonandjohnson-cancer/ Dr David Kelly, start with this if you're new to the War in Iraq: https://www.theguardian.com/politics/2013/jul/16/david-kelly-death-10-years-on The "coin shortage", not widely reported in the UK, is here: https://www.washingtonpost.com/business/2020/09/01/coin-shortage-pandemic/ The "digital dollar" project: https://www.digitaldollarproject.org/ The Infectious Myth website: https://theinfectiousmyth.com/ The Contagion Myth is here: https://www.simonandschuster.co.uk...
2020-11-081h 42
Greener Thoughts5 Better Alternatives to Talc Powder!#thickthighssave lives, and because they do protect your lady part nether regions and BOTH women and men guard your armpits because this podcast episode is what your pits need! #babypowder #baby #JohnsonandJohnson #beautyindustry #greenerthoughtspodcast
CORRECTION: captainblankenship.com NOT captainblanketship.com.
Announcements: 1) www.snowleopard.org
Resources from the podcast: 1) https://science.sciencemag.org/content/365/6459/eaaw1944 - ANTIBIOTIC RESISTANCE JOURNAL ARTICLE, 2) https://schmidts.com/recycling-club - How Schmidt's does rewards recycling!
Related podcast episodes: My podcast episode where I featured some of the brands mentioned in my special segment: 1) - Nubian Heritage (February 28, 2019) "Pest...
2019-10-2151 min